• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.82% Nasdaq Down2.08%

    Rosetta Genomics, Ltd. (ROSG)

    -NasdaqCM
    0.85 Down 0.04(4.06%) 12:13PM EST
    ProfileGet Profile for:
    Rosetta Genomics, Ltd.
    10 Plaut Street
    Science Park
    Rehovot, 76706
    Israel - Map
    Phone: 972 73 222 0700
    Fax: 972 73 222 0701
    Website: http://www.rosettagenomics.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Laboratories & Research
    Full Time Employees:52

    Business Summary 

    Rosetta Genomics Ltd. develops and commercializes microRNAs based diagnostic tests and therapeutics. MicroRNAs are a group of genes that are produced using instructions encoded in DNA. The company offers diagnostic tests, including Rosetta Cancer Origin test, a microRNA-based diagnostic to identify 42 tumor types that include carcinomas, soft tissue tumors, lymphoma, and other malignancies; Rosetta Mesothelioma test to differentiate mesothelioma, a cancer connected to asbestos exposure and other risk factors, from other carcinomas in the lung and pleura; Rosetta Lung Cancer test, a lung cancer classification test for cytology samples; and Rosetta Kidney Cancer test, a microRNA-based kidney tumor classification test for pathology samples. It is also developing a test for the differential diagnosis of indeterminate thyroid fine needle aspirate samples; blood or urine based microRNA biomarkers to develop a diagnostic test for chronic kidney rejection; blood-based microRNA biomarkers to develop a diagnostic test for early diagnosis of heart failure and refined risk stratification of patients following myocardial infarction; tissue-based microRNA biomarkers to develop a test for the risk stratification of patients with non-muscle-invasive bladder cancer; tissue-based microRNA biomarkers to develop a test for the pre-surgical risk stratification of patients with endometrial cancer; and microRNA-based diagnostic test for the early diagnosis of Alzheimer’s disease. The company distributes its products primarily in Australia, Canada, Greece, India, Israel, New Zealand, Qatar, Romania, Saudi Arabia, Singapore, Turkey, and the United Arab Emirates. Rosetta Genomics Ltd. was founded in 2000 and is based in Rehovot, Israel.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Rosetta Genomics, Ltd.

    Key Executives 
     PayExercised
    Mr. Kenneth A. Berlin , 52
    Chief Exec. Officer and Pres
    834.00K0.00
    Mr. Ron Kalfus CPA, 42
    Chief Financial Officer and Principal Accounting Officer
    176.00K0.00
    Dr. Dganit Bar Ph.D., 47
    Chief Scientific Officer
    197.00K0.00
    Mr. Oded Biran Adv., 37
    Gen. Counsel and Sec.
    292.00K0.00
    Mr. Doug Sites ,
    Exec. VP of Sales & Marketing
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.